Company news

Innoviva, Inc. news in 2024

Innoviva, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)

December 15, 2024

Innoviva to Participate in the Citi 2024 Global Healthcare Conference

November 25, 2024

Innoviva to Participate in the UBS Global Healthcare Conference

November 11, 2024

Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress

November 5, 2024

Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress

July 30, 2024

Innoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

June 2, 2024

Innoviva to Participate in the BofA Securities Health Care Conference

May 7, 2024

Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress

May 7, 2024

Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024

April 23, 2024

Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress

February 28, 2024

Decks in 2024